Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
14.6M
-
Number of holders
-
35
-
Total 13F shares, excl. options
-
9.23M
-
Shares change
-
+8.89M
-
Total reported value, excl. options
-
$179M
-
Value change
-
+$172M
-
Number of buys
-
33
-
Price
-
$19.38
Significant Holders of Neurogene Inc. - Common Stock (NGNE) as of Q4 2023
35 filings reported holding NGNE - Neurogene Inc. - Common Stock as of Q4 2023.
Neurogene Inc. - Common Stock (NGNE) has 35 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.23M shares
of 14.6M outstanding shares and own 63.36% of the company stock.
Largest 10 shareholders include EcoR1 Capital, LLC (1.27M shares), Samsara BioCapital, LLC (1.27M shares), GREAT POINT PARTNERS LLC (994K shares), Redmile Group, LLC (947K shares), JANUS HENDERSON GROUP PLC (842K shares), Cormorant Asset Management, LP (746K shares), ArrowMark Colorado Holdings LLC (526K shares), Casdin Capital, LLC (525K shares), Avidity Partners Management LP (466K shares), and BAKER BROS. ADVISORS LP (454K shares).
This table shows the top 35 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.